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Background: One of side effects of chemotherapy and radiotherapy is the induction of several factors in various
tissues and organs that create a pro-metastatic microenvironment for cancer cells that survive initial treatment.
Methods: In the present study, we employed human ovarian cancer cell line A2780 and immunodeficient mice
xenogrfat model to test effect of both ibuprofen and dexamethasone to ameliorate the therapy-induced pro-metastatic
microenvironment in bone marrow, liver, and lung.
Results: In our studies, we found that total body irradiation or administration of cisplatin increases the metastatic
spread of human ovarian cancer cells transplanted into immunodeficient mice compared with animals unexposed
to irradiation or cisplatin. Moreover, conditioned media harvested from irradiated murine bone marrow, lung, and liver
chemoattracted human ovarian cancer cells, and this chemotactic activity was inactivated by heat, suggesting a major
involvement of peptide or peptide-bound chemoattractants. We also observed that human ovarian cancer cells
proliferate better if exposed to cell debris harvested from irradiated murine bone marrow. Finally, the pro-metastatic
microenvironment in mice induced by radio- or chemotherapy was significantly ameliorated if animals were treated
at the time of radiotherapy administration with non-steroid (ibuprofen) or steroid (prednisone) anti-inflammatory
drugs.
Conclusions: In summary, we propose that a radiochemotherapy-induced, pro-metastatic microenvironment plays an
important role in the metastasis of cancer cells that are resistant to treatment. Such cells have characteristics of cancer
stem cells and are highly migratory, and simple, intensive, anti-inflammatory treatment by non-steroid agents to
suppress induction of pro-metastatic factors after radiochemotherapy would be an interesting anti-metastatic
treatment alternative.
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After surgical removal of tumor tissue, chemotherapy and
radiotherapy are the most efficient treatment modalities
employed in clinical oncology. Unfortunately, anti-cancer
treatment is usually associated with toxicity to non-tumor
cells, resulting in different degrees of damage to tissues
and organs [1,2]. There are well-known side effects of
chemotherapy and radiotherapy that are mainly related to
the toxicity to, and impaired function of, vital organs;
however, the induction by these therapies of the expres-
sion of several factors in various organs that create a pro-
metastatic microenvironment, is, surprisingly, not widely
acknowledged.
In support of the reality of this effect, it is very well
known that normal hematopoietic stem cells, after infu-
sion into a host following myeloablative radiochemother-
apy, home efficiently to bone marrow (BM) in response
to several chemotactic factors upregulated in the BM
microenvironment [3-5]. To explain this phenomenon,
we hypothesized that toxic damage to BM and other or-
gans as a result of radio and/or chemotherapy treatment
of malignancies leads to upregulation of factors that at-
tract normal circulating stem cells for regeneration but,
unfortunately, also provide chemotactic signals to cancer
cells that survive the initial treatment [1,6,7]. These cells
may then establish tumor metastases.
In support of toxic damage as a driver of metastasis, we
as well as others have demonstrated that exposure of mice
to irradiation [8,4], cyclophosphamide [8,9], or vincristine
[6,7] upregulates the levels of several chemokines and
growth factors, such as stromal-derived factor 1 (SDF-1),
hepatocyte growth factor/scatter factor (HGF/SF), vas-
cular endothelial growth factor (VEGF), and monocyte
chemotactic protein 1 (MCP-1), in the BM microenvir-
onment [8-11]. We predicted that a similar response
would accompany the toxic effects of chemotherapy or
radiotherapy in other sensitive organs, including liver
and lung [1,6,7].
In the present study, we report that conditioned medium
(CM) from irradiated BM, lung, and liver chemoattracts
human ovarian cancer cells in vitro. Next, by employing a
short in vivo tumor cell tissue-seeding assay, we observed
that increased numbers of human cancer cells seed
(metastasize) to the BM and other organs in SCID-Beige
immunodeficient mice after irradiation or exposure to
chemotherapy. In addition, we observed that human cancer
cells expanded more strongly in culture in the presence of a
feeder layer of cell debris from damaged or dying human
BM cells. Finally, we were able to (1) ameliorate the in vitro
migration of cancer cells to CM harvested from irradiated
tissues and (2) decrease seeding of in vivo-injected human
cells into various organs in irradiated or chemotherapy-
exposed mice by reducing the pro-inflammatory response
induced by radiochemotherapy, due to administering eitherof the non-steroid anti-inflammatory drugs ibuprofen or
dexamethasone.
We propose that a radiochemotherapy-induced pro-
metastatic microenvironment, which plays an important
but underappreciated role in the metastasis of cancer cells
to bone and other organs (lungs or liver), can be amelio-
rated by a simple, intensive treatment by non-steroid and
steroid anti-inflammatory agents to suppress induction of
pro-metastatic factors by radiochemotherapy.
Material and methods
Cell lines
The A2780 ovarian epithelial cancer cell line was main-
tained in Roswell Park Memorial Institute (RPMI)
medium 1640, containing 10% FBS, 100 U/ml penicillin,
and 10 μg/ml streptomycin. Cells were cultured in a hu-
midified atmosphere of 5% CO2 at 37°C, and the medium
was changed every 48 hours.
Peritoneal tumor formation in mice
All procedures involving animals and their care were ap-
proved by the Institutional Animal Care and Use Commit-
tee, according to the guidelines of the association for
Assessment and Accreditation of Laboratory Animal Care
of the University of Louisville (Louisville, KY, USA).
Human ovarian cancer cells (2.5 × 106) were inocu-
lated into the peritoneal cavity of SCID-Beige inbred
mice, and seven mice were used for each group. The
mice were monitored for peritoneal swelling and any ad-
verse effects and euthanized after 3–5 weeks of cell in-
oculation. Visible tumor nodules were excised and
collected and were measured for size.
Injection of A2780 cells into immunodeficient mice
To evaluate the in vivo metastatic behavior of A2780 cells,
cells were injected intravenously (i.v.; 2 × 106 per mouse)
into severe combined immunodeficient (SCID)-Beige in-
bred mice and divided into four groups (five mice per
group). Group i) control (non-irradiated mice), ii) irradi-
ated with 1000 cGy 24 hours prior to injection of A2780
cells, iii) control (untreated and non-irradiated), and iv)
injected with cisplatin (5 mg/kg of body weight of mice)
anticancer drug.
In a second experiment, mice were injected with an
anti-inflammatory drug prior to irradiation (five mice
per group). Mice were grouped as i) control (untreated
and non-irradiated), ii) irradiated with 1000 cGy 24 h
prior to injection of A2780 cells, iii) injected with ibu-
profen (40 mg/kg of body weight of mice) only, iv)
injected with ibuprofen (40 mg/kg of body weight of
mice) and irradiated with 1000 cGy, v) injected with
dexamethasone (2.5 mg/kg body weight of mice) only,
and vi) injected with dexamethasone (2.5 mg/kg body
weight of mice) and irradiated with 1000 cGy. In both
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cells only. Experimental strategies are shown in (Figure 1).
Bone marrows, spleens, livers, and lungs were removed
48 hours after injection of these cells, and the presence of
ovarian cells (i.e., murine–human chimeras) was evaluated
by the level of human α-satellite DNA expression. DNA
was amplified in the extracts isolated from BM-, spleen-,
liver-, and lung-derived cells using real-time PCR. Briefly,
DNA was isolated using the QIAamp DNA Mini kit
(Qiagen), and human satellite and murine β-actin DNA
levels was detected by means of real-time PCR using an
ABI Prism 7500 Sequence Detection System. A 25-μl
reaction mixture containing 12.5 μl SYBR Green PCR
Master Mix, 300 ng DNA template, forward (5′-ACC
ACT CTG TGT CCT TCG TTC G-3′) and reverse (5′-
ACT GCG CTC TCA AAA GGA GTG T-3′) primers for
the α-satellite, and forward (5′-TTC AAT TCC AAC ACT
GTC CTG TCT -3′) and reverse (5′- CTG TGG AGT
GAC TAA ATG GAA ACC -3′) primers for the β-actin
were used. The Ct value was determined as described pre-
viously [7], and the number of human cells present in the
murine organs (the degree of chimerism) was calculated
from the standard curve obtained by mixing different num-
bers of human cells with a constant number of murineFigure 1 Radiochemotherapy and anti-inflammatory drug injection strat
consecutive days, −D1, D0, and D1, and A2780 cells were transplanted 24 hrs a
irradiation at 1000 cGy on –D1, prior to A2780 cell injection. SCID-Beige inbred
for five consecutive injections (−12 hrs, 0 hrs, +12 hrs, +24 hrs, +36 hrs) and un
celltransplantation. All drugs were injected at doses explained in the figure. All
marrows, spleens, livers, and lungs were collected. The presence of ovarian cell
α-satellite DNA expression.cells. In long-term experiments, cells (2.5 × 106 per mouse)
were inoculated intraperitoneally into SCID-Beige inbred
mice (seven mice per group). Four weeks later, the mice
were sacrificed for evaluation of the A2780 cells present in
BM, spleen, liver, and lung. Detection of human cells was
performed as described below (Additional file 1: Figure S1,
panel A).
Flow cytometric analysis of HLA expression
BM cells were harvested from mice at day 30 following
transplantation of A2780 cells. Mice were grouped (four
mice per group) according to treatment: i) no irradiation
or ii) irradiation with 1000 cGy 24 hours prior to A2780
cell transplantation. BM cells were then washed twice
with sterile PBS and incubated with 1X RBC lysis solu-
tion, and the intact cells were stained for human
leukocyte antigen (HLA) Additional file 1: Figure S1,
panel B. Staining was performed in PBS with 2% fetal
bovine serum (FBS, Invitrogen, Carlsbad, CA), at 4°C for
30 min. Cells were subsequently washed, resuspended,
and analyzed using an LSR II flow cytometer (BD Biosci-
ences). At least 1.5 × 106 events were acquired from
each sample, and FlowJo software was used for analysis
(Tree Star, Ashland, OR).egy. SCID-Beige inbred mice received a chemodrug (cisplatin) for three
fter the first cisplatin injection. Similarly, SCID-Beige inbred mice underwent
mice also received anti-inflamatory drugs (ibuprofen or dexamethasone)
derwent irradiation at 1000 cGy at 0 hrs, followed immediately by A2780
mice were sacrificed 48 hours after the injection of A2780 cells, and bone
s (i.e., murine–human chimeras) was evaluated by the level of human
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Pathogen-free C57BL/6 mice (7–8 weeks old) were used
for these experiments. Mice (four per group) were irradi-
ated with 1000 cGy, and 24 hours later, bone marrow,
liver, and lung were isolated. Conditioned medium (CM)
was obtained after 3 hours of incubation of BM, liver, or
lung cells (mechanically homogenized 30x using a syr-
inge) in RPMI at 37°C. After centrifugation, the super-
natant was used for further experiments. In studies with
anti-inflammatory drugs, mice were injected intraperito-
neally with ibuprofen (40 mg/kg) or dexamethasone
(2.5 mg/kg) prior to irradiation with 1000 cGy. Twenty-
four hours later, organs were isolated, and CM from
various organs was prepared as described above.
Chemotaxis assay
Chemotaxis assays were performed in a modified Boyden’s
chamber with 8-μm pore polycarbonate membrane inserts
(Costar Transwell; Corning Costar, Lowell, MA, USA) as
described previously [7]. In brief, cells were detached with
0.05% trypsin and seeded into the upper chamber of an in-
sert at a density of 5 × 104 in 110 μl. The lower chamber
was filled with pre-warmed CM harvested from the differ-
ent organs from irradiated SCID-Beige mice at 1000 cGy.
Medium supplemented with 0.5% BSA was used as a
negative control, and medium supplemented with 10%
FBS was used as a positive control. After 48 hours, the in-
serts were removed from the Transwell supports. The cells
that had not migrated were scraped from the upper
membrane with a cotton swab, and the cells that had
transmigrated to the lower side of the membrane were
fixed and stained with HEMA 3 (Protocol, Fisher Scien-
tific, Pittsburgh, PA) and counted on the lower side of
the membrane using an inverted microscope.
Temperature effect on BM CM
CM samples from irradiated mouse BM were subjected
to a range of temperatures. In particular, they were: i) in-
cubated for 30 min at 37°C, 42°C, 56°C, or 90°C and ii)
subjected to three frost–defrost cycles, which were car-
ried out by incubating these CM samples at −80°C and
subsequently in a water bath at 37°C. The samples were
then directly used for chemotaxis experiments, and any
residual samples were stored at −80°C for further use.
Molecular centrifugation of BM CM
CM samples from irradiated mouse BM were centrifuged
at 3000 × g for 30 min in Centricon centrifugal filter de-
vices (Millipore) until the entire sample had passed through
the column. These devices were used for the separation of
proteins and peptides, covering a range of molecular-weight
cutoffs (10, 30, 50, and 100 kDa). CM samples filtered and
concentrated using different molecular-weight cutoffs were
then used for chemotaxis assays with A2780 cells.Invasive potential of ovarian cancer cells grown on dying
or damaged bone marrow cells
C57BL/6 GFP mice were grouped (three per group) as
non-irradiated or irradiated (with 1000 cGy). Twenty-
four hours later, bone marrow, liver, and lung were iso-
lated, and CM samples were obtained from these organs,
as described above. After 3 hours, cells flushed from
bone marrow were then co-cultured with A2780 cells
(1000 cells/well in 24-well plates). Both BM cells and
CM samples from other organs were analyzed as a
growth-supporting medium for A2780 cells. Forty eight
hours later, A2780 cell clusters were counted and photo-
graphed under a fluorescence microscope, and GFP-
expressing BM cells were also counted by FACS.
Statistical analysis
All results were presented as mean ± SD. Statistical ana-
lysis of the data was performed using the nonparametric
Mann–Whitney test (animal studies) and Student’s t test
for unpaired samples by using Graph Pad Prism soft-
ware. P < 0.05, P < 0.005 and P < 0.0005 were considered
significant.
Results
Increased seeding efficiency of human ovarian cancer
cells in a mouse xenograft model after chemotherapy and
irradiation
To test the hypothesis that chemotherapy and irradiation
induce a pro-metastatic microenvironment in various or-
gans, immunodeficient SCID-Beige mice were exposed to
three doses of cisplatin (5 mg/kg bw) administered i.p. on
days −1, 0, and +1 after i.v. injection of A2780 human
ovarian cancer cells (2 × 106 cells/mouse). In parallel, ex-
perimental mice were irradiated with 1000 cGy on day −1
before i.v. injection of ovarian cancer cells at the dose de-
scribed above. Control mice were neither exposed to cis-
platin nor irradiated. Mice were sacrificed 48 hours after
cell injection, and cell suspensions from bone marrow,
spleen, lung, and liver were prepared and DNA extracted
for real-time PCR analysis of human Alu sequences. Based
on standard curves, different levels of Alu sequence ex-
pression were converted to the number of human cells
present in murine tissues. Figure 2 shows that we were
able to detect a significant increase in human ovarian can-
cer cells present in BM, liver, spleen, and lung in mice that
were exposed to cisplatin or were irradiated.
Anti-inflammatory treatment at the time of irradiation
reduces the metastatic spread of human ovarian cancer
cells in immunodeficient mice
Based on the observation that irradiation results in damage
to several organs and induces a pro-metastatic microenvir-
onment that may promote the spread of cancer cells, we
tested whether administration of anti-inflammatory drugs
Figure 2 Chemotherapy and irradiation create a pro-metastatic microenvironment in various murine organs that chemoattract A2780 cells.
qRT-PCR detection of A2780 human ovarian cancer cells in bone marrow (BM), liver, lung, and spleen after irradiation (1000 cGy) and chemotherapy
(cisplatin). Five mice were employed per group. The results from two independent experiments are combined and shown as mean ± SD. *p < 0.05 or
**p < 0.005 compared with control (organs neither irradiated nor received cisplatin).
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ian cancer cells to different organs. In this experiment we
administered ibuprofen (40 mg/kg bw) or dexamethasone
(2.5 mg/kg) to mice at −12 hrs and subsequently at 0, +12,
+24 and +36 hrs after irradiation. Employing ibuprofen or
dexamethasone as an anti-inflammatory treatment showed
a significant effect in ameliorating metastatic spread ofFigure 3 Anti-inflammatory treatments inhibit the metastatic spread
significantly decrease the metastatic spread of A2780 human cancer cells in
mice. In these experiments, five mice were used per group, and the results
are shown as mean ± SD. *p < 0.05, **p < 0.005, or ***p < 0.0005 for the gro
(no irradiation) and for the groups receiving irradiation and an anti-inflammovarian cancer cells that were injected i.v. with A2780 cells
3 hours after irradiation (Figure 3 panels A and B).
Human ovarian cancer cells respond to a chemotactic
gradient of factors released from irradiated organs
Next, we collected conditioned media (CM) from organs
harvested from irradiated SCID-Beige mice. Animalsof A2780 cells. Ibuprofen (Panel a) and dexamethasone (Panel b)
to bone marrow (BM), liver, lung, and spleen of SCID-Beige inbred
from three independent experiments for each anti-inflammatory drug
up receiving irradiation (1000 cGy) compared with the control group
atory drug compared with the group receiving irradiation alone.
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gans were removed and cell suspensions were incubated
for 3 hours. Finally, CM samples were prepared by re-
moving cells and cell debris by high-speed centrifugation
and employed as a source of chemoattractants that were
placed in the lower chambers in Transwell migration as-
says. In parallel, we prepared CM samples from irradiated
mice treated with ibuprofen. We observed a significant
chemotactic effect of CM harvested from irradiated BM
liver, and lung and a significant decrease in chemotactic
activity in CM prepared from organs isolated from
ibuprofen-treated irradiated animals (Figure 4A).
Based on these results, we became interested in pin-
pointing the molecular characteristics of the chemotactic
factors present in CM harvested from BM. Figure 4B
shows an initial analysis of these CM sample by employing
heat inactivation (left panel) and molecular centrifugation
(right panel). The results indicate that chemotactic factors
are heat sensitive, which suggests a peptide- or protein-
associated structure, and are in the range of 30–50 kDa in
size. We are currently trying to identify these factors by
employing mass spectrophotometry analysis.
Lethally irradiated BM tissue supports growth of human
cancer cells
Based on the findings that irradiated BM chemoattracts
human ovarian cancer cells, we tested another hypoth-
esis: that damaged BM tissue supports expansion ofFigure 4 Conditioned media (CM) derived from irradiated organs are p
across Transwell membranes in response to CM harvested from BM, liver,
b. Chemotaxis of A2780 cells across Transwell membranes in response to
temperatures (left panel) and derived from molecular filtration by using Centr
performed at least three times in duplicate, with similar results. Results ar
**p < 0.005 relative to the control (cells stimulated with RPMI 0.5% BSA mmetastasizing cancer cells. To address this issue, trans-
genic green immunofluorescence (GFP+) mice were le-
thally irradiated with 1000 cGy. BM cells were recovered
24 hrs later from bone and plated without washing into
24-well culture plates. After 3 hours, A2780 cells were
added at 103/well. Established in this way, co-cultures of
irradiated murine BM cells and human A2780 cancer
cells were evaluated after 48 hours. Figure 5A shows
representative images of the effect of non-irradiated
(upper panel) and irradiated (lower panel) BM cells on
the clonal expansion of human ovarian cancer cells. One
can see that debris from irradiated BM cells increases
proliferation of A2780 cells (right panel). To quantify
this data, the number of A2780 cell clusters was counted
in wells containing non-irradiated (control) and irradi-
ated BM cells (Figure 5B, left panel). In parallel experi-
ments (Figure 5B, right panel), we also evaluated the
effect of CM harvested from non-irradiated and irradi-
ated BM, lung, and liver on proliferation of A2780 cells
and observed a similar positive effect on human cancer
cell growth.
Discussion
The coincidence between inflammation and tumorogenesis
is well established as well as the fact that cancer frequently
develops in tissues exposed to chronic inflammation
[12,13], which orchestrates the microenvironment around
growing tumors, contributing to proliferation, survival, andotent chemoattractants for A2780 cells. a. Chemotaxis of A2780 cells
and lung of irradiated and ibuprofen-treated SCID-beige inbred mice.
irradiated BM CM samples subjected to heat inactivation at different
icon centrifugal filtration devices (right panel). The chemotaxis assay was




) BM cells + A2780 cells
IRR (1000 cGy) 
No IRR  
Figure 5 Damaged bone marrow cells and CM harvested from organs from irradiated mice support A2780 cell growth in vitro. a. Proliferation
and expansion of A2780 cells co-cultured with irradiated BM cells from C57BL/6 GFP mice for 48 hours, showing that irradiation causes lethally damaging
effects to BM cells that result in the release of growth- and metastasis-promoting factors in vitro. Non-irradiated BM cells showed little or no effect on the
growth of A2780 cells (upper panel). On the other hand, irradiated BM cells support the rapid and spontaneous growth of A2780 cell clusters
(lower panel). b. Microscopic count of A2780 cell clusters found per well (24-well culture plate) after 48 hours of co-culture with irradiated and
non-irradiated BM cells (left panel). Microscopic count of A2780 cell clusters after 48 hours of co-culture with CM samples harvested from BM,
lung, and liver from irradiated and non-irradiated mice. (right panel). This co-culture experiment was repeated twice. In each experiment, six mice were
employed per group (n = 3, no-irradiation control; n = 3, irradiation at 1000 cGy). Microscopic counts were made in triplicate from the wells, with
significant results. Results are presented as means ± SD, with a statistical significance *p < 0.05, **p < 0.005, or ***p < 0.0005 relative to the control
(A2780 cells cultured in RPMI 0.5% BSA medium).
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prising that both non-steroid and steroid anti-inflammatory
drugs are employed in cancer patients in some protocols
[15,16].
Specifically, non-steroid, anti-inflammatory drugs such
as the cyclooxygenase-1 and −2 inhibitor ibuprofen or
the more potent and selective COX-2 inhibitor celecoxib
appear to reduce the risk of developing cancer and may
inhibit prostaglandin- and thromboxane-dependent cell
division, metastasis, and angiogenesis and promote the
apoptosis of malignant cells [17,18]. On the other hand,synthetic corticosteroids, such as dexamethasone, are also
used in oncology in patients undergoing chemotherapy to
counteract certain side effects, such as emesis, or to coun-
teract edema in brain tumors [19,20]. Dexamethasone is
also used as a direct chemotherapeutic agent in certain
hematological malignancies [21,22].
In the present study, we employed both ibuprofen and
dexamethasone to ameliorate the therapy-induced pro-
metastatic microenvironment in bone marrow, liver, and
lung. Based on our experimental models and results, we
propose a potential application of anti-inflammatory
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2 inhibitor or dexamethasone at the time of radiochemo-
therapy to reduce the metastatic spread of cancer cells to
different organs. This strategy is based on the finding that
exposure of mice to γ-irradiation or systemic administra-
tion of cisplatin induces a pro-metastatic microenviron-
ment in BM, liver, spleen and lung (Figures 2 and 3). The
salient observation of our work is that administration of
ibuprofen or dexamethasone at the time of radiochemo-
therapy inhibits the spread of human ovarian cancer cells
to several organs of immunodeficient mice. This is rela-
tively a simple approach that is effective at significantly
decreasing the seeding efficiency of human malignant cells
to several organs after they are injected intravenously.
This essay has been developed by our group to study early
metastatic spread of tumor cells [6,7]. However, we are
aware that more experiments are needed to evaluate
metastatic potential of cancer cells over time. We also
show that ovarian cancer cells grow and expand much
better when exposed to debris from BM-irradiated cells.
Again, these studies performed on established tumor cell
line need further clarification in real clinical settings
employing patient cancer cells that survived radio-
chemotherapy treatment.
It is well known that metastasis is responsible for more
than 90% of cancer-associated mortality [23,24] and is a
multistep process in which induction of a pro-metastatic
microenvironment within tumors and at distant loca-
tions plays a crucial role. Chemotactic factors emerging
in damaged tissues may induce an undirected motility of
cancer cells, described as chemokinesis [25], or a di-
rected migration, known as chemotaxis [26]. In response
to chemokinesis and/or chemotaxis, cancer cells leave a
primary tumor, infiltrate surrounding tissues, and may
enter the lymphatics or peripheral blood to metastasize
to remote organs [1,6-8]. Several peptide-based and
non-peptide-based factors, such as bioactive lipids or
extracellular nucleotides, have been described as indu-
cing the motility of cancer cells [4,6,7,27]. On the other
hand, enhanced migratory properties are one of the key
features of stem cells [28]. The comparatively strong re-
sistance of cancer therapy supports the concept of pres-
ence of cancer stem cells [29-32]. These cells would
survive treatment and are most likely responsible for
malignant spread after the initial reduction of the pri-
mary tumor. Since metastasis and tumor spread is a
major factor limiting survival of cancer patients, the
clinical need to prevent or target metastasis is a thera-
peutic priority in clinical oncology.
It is well known that tumors respond to several pro-
metastatic chemotactic factors, and therefore it would
be difficult to inhibit their metastatic potential by inhi-
biting just one or even a few receptor axes [4,6,7,33]. For
example, in a model of metastatic rhabdomyosarcoma,we previously demonstrated that exposure to irradiation
[4,6,7] or chemotherapy [6-8] of several organs upregu-
lates the levels of chemokines and growth factors, such
as SDF-1, HGF/SF, VEGF, and MCP-1, in addition to
bioactive lipids such as S1P, C1P, LPA, and LPC, which
are endowed with strong chemotactic activities with re-
spect to normal as well as malignant cells [3,6,7]. As in
chemotherapeutics, exposure to irradiation leads also to
the release of several alarmines (e.g., ATP and UTP)
from the damaged cells (manuscript in preparation).
Moreover, in several well-controlled animal experimental
models, it has been demonstrated that blockade of
CXCR4 [4,33,34], CXCR7 [35], or c-Met [4,36] receptors
by employing small-molecule inhibitors; downregulation
of these receptors by shRNA strategies [27,37]; in vivo
administration of blocking antibodies against SDF-1
[38] or MCP-1 [39,40]; or application of S1P-binding
aptamers [6] significantly diminishes chemotherapy- or
radiotherapy-related dissemination of tumor cells to
various organs. Since it is impossible to target all these
pro-metastatic factors at the same time, it is obvious
that future anti-metastatic drugs must depend on po-
tent molecules that interfere with migration and adhe-
sion processes of cancer cells downstream of the
surface receptors for these pro-metastatic factors.
However, the aim of our current work was not to iden-
tify particular factors involved in radiochemotherapy-
induced metastatic spread of cancer cells. but rather to
broadly characterize their molecular properties. Our pre-
liminary experiments, performed in a model of human
ovarian cancer, indicate the involvement of temperature-
sensitive factors that are present in the 30–50-kDa frac-
tion of normal serum. While this fraction is most likely
to contain a peptide-based chemoattractant (s), we can-
not exclude the possibility that it may contain certain
bioactive lipids that are associated with proteins. Further
studies will address this issue. We are also aware that
the metastatic spread of cancer cells after radiochemo-
therapy could also be promoted by other mechanisms.
One of these mechanisms could be direct toxicity to the
endothelial wall, which affects the integrity of the endo-
thelial barrier, and may facilitate seeding of cancer cells
into damaged organs through the disrupted endothelium
[9]. Another possibility is that membrane fragments (e.g.,
exosomes or microvesicles) have been shown in several
animal models to be endowed with chemotactic properties
[41,42]. Furthermore, we must remember that our results
were obtained with a human ovarian cancer cell line, and
cells from other tumors may respond differently to a panel
of chamoattractants.
In conclusion, we propose that a radiochemotherapy-
induced pro-metastatic microenvironment plays an
important role in the metastasis of cancer cells that are
resistant to treatment. Such cells possess characteristics
Gunjal et al. Journal of Ovarian Research  (2015) 8:20 Page 9 of 10of cancer stem cells and are highly migratory, and a
simple, intensive treatment with anti-inflammatory
agents to suppress induction of pro-metastatic factors
after radiochemotherapy is an interesting treatment al-
ternative. However, this hypothesis requires further dose-
optimization studies and validation in appropriate clinical
trials. Finally, as we have also demonstrated in a model of
irradiated BM, cell debris from organs damaged by radio-
chemotherapy may support expansion of cancer cells and
could provide an underappreciated “fertile soil” for metas-
tasizing cancer cells, as suggested in the well-known seed
and soil hypothesis of cancer metastasis [43].
Additional file
Additional file 1: Figure S1. Intraperitoneal murine model of A2780 cell
metastasis. A. Metastatic behavior measured by qRT-PCR detection of
human ovarian cancer cells (A2780) in various organs on day 30 after
intraperitoneal injection into SCID-beige inbred mice. Bilateral ovarian
tumors found in mice transplanted with A2780 cells (right box) compared
with control mice (left box). In this experiment, seven mice were employed
per group, and results are presented as mean ± SD, with a statistical
significance *p < 0.05 or **p < 0.005 relative to the control mice (untreated
with A2780 cells). B. FACS detection of human leukocyte antigen-positive
(HLA+) cells in bone marrow (BM) harvested from intraperitoneally injected
and irradiated (1000 cGy) SCID-Beige inbred mice on day 30. In this
experiment, four mice were employed per group, and results are presented
as means ± SD, with a statistical significance *p < 0.05 or **p < 0.005 relative
to the control mice (no irradiation).
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